Cargando…
Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients
Colorectal carcinoma is uncommon in Egypt, but a high proportion of cases occurs before age 40 years and in the rectum. We compared the molecular pathology of 59 representative Egyptian patients aged 10–72 to Western patients with sporadic, young-onset, or hereditary non-polyposis colorectal cancer...
Autores principales: | , , , , , , , , , , , , , , |
---|---|
Formato: | Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group
2001
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375101/ https://www.ncbi.nlm.nih.gov/pubmed/11592777 http://dx.doi.org/10.1054/bjoc.2001.1838 |
_version_ | 1782154577506729984 |
---|---|
author | Soliman, A S Bondy, M L El-Badawy, S A Mokhtar, N Eissa, S Bayoumy, S Seifeldin, I A Houlihan, P S Lukish, J R Watanabe, T Chan, A On On Zhu, D Amos, C I Levin, B Hamilton, S R |
author_facet | Soliman, A S Bondy, M L El-Badawy, S A Mokhtar, N Eissa, S Bayoumy, S Seifeldin, I A Houlihan, P S Lukish, J R Watanabe, T Chan, A On On Zhu, D Amos, C I Levin, B Hamilton, S R |
author_sort | Soliman, A S |
collection | PubMed |
description | Colorectal carcinoma is uncommon in Egypt, but a high proportion of cases occurs before age 40 years and in the rectum. We compared the molecular pathology of 59 representative Egyptian patients aged 10–72 to Western patients with sporadic, young-onset, or hereditary non-polyposis colorectal cancer syndrome (HNPCC)-associated carcinoma and found significant differences. Most Egyptian cancers were rectal (51%) and poorly differentiated (58%). High levels of microsatellite instability (MSI-H) were frequent (37%) and attributable in some cases (36%) to methylation of the promoter of the hMLH1 mismatch repair gene, but no MSI-H cancer had loss of hMSH2 mismatch repair gene product of the type seen with germline hMSH2 mutation in HNPCC. K-ras mutation was uncommon (11%). In subset analyses, high frequencies of MSI-H in rectal carcinomas (36%) and p53 gene product overexpression in MSI-H cancers (50%) were found. MSI-H and K-ras mutation in Egyptians under age 40 were unusual (17% and 0%, respectively), and schistosomiasis was associated with MSI and K-ras mutation. Cluster analysis identified 2 groups: predominantly young men with poorly differentiated mucinous and signet-ring cell colorectal carcinoma lacking K-ras mutation; older patients who had well- or moderately differentiated adenocarcinoma often with MSI-H, K-ras mutation and schistosomiasis. Our findings show that the molecular pathology of colorectal cancer in older as well as younger Egyptians has unique differences from Western patients, and schistosomiasis influences the molecular pathogenesis of some tumours. © 2001 Cancer Research Campaignhttp://www.bjcancer.com |
format | Text |
id | pubmed-2375101 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2001 |
publisher | Nature Publishing Group |
record_format | MEDLINE/PubMed |
spelling | pubmed-23751012009-09-10 Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients Soliman, A S Bondy, M L El-Badawy, S A Mokhtar, N Eissa, S Bayoumy, S Seifeldin, I A Houlihan, P S Lukish, J R Watanabe, T Chan, A On On Zhu, D Amos, C I Levin, B Hamilton, S R Br J Cancer Regular Article Colorectal carcinoma is uncommon in Egypt, but a high proportion of cases occurs before age 40 years and in the rectum. We compared the molecular pathology of 59 representative Egyptian patients aged 10–72 to Western patients with sporadic, young-onset, or hereditary non-polyposis colorectal cancer syndrome (HNPCC)-associated carcinoma and found significant differences. Most Egyptian cancers were rectal (51%) and poorly differentiated (58%). High levels of microsatellite instability (MSI-H) were frequent (37%) and attributable in some cases (36%) to methylation of the promoter of the hMLH1 mismatch repair gene, but no MSI-H cancer had loss of hMSH2 mismatch repair gene product of the type seen with germline hMSH2 mutation in HNPCC. K-ras mutation was uncommon (11%). In subset analyses, high frequencies of MSI-H in rectal carcinomas (36%) and p53 gene product overexpression in MSI-H cancers (50%) were found. MSI-H and K-ras mutation in Egyptians under age 40 were unusual (17% and 0%, respectively), and schistosomiasis was associated with MSI and K-ras mutation. Cluster analysis identified 2 groups: predominantly young men with poorly differentiated mucinous and signet-ring cell colorectal carcinoma lacking K-ras mutation; older patients who had well- or moderately differentiated adenocarcinoma often with MSI-H, K-ras mutation and schistosomiasis. Our findings show that the molecular pathology of colorectal cancer in older as well as younger Egyptians has unique differences from Western patients, and schistosomiasis influences the molecular pathogenesis of some tumours. © 2001 Cancer Research Campaignhttp://www.bjcancer.com Nature Publishing Group 2001-09 /pmc/articles/PMC2375101/ /pubmed/11592777 http://dx.doi.org/10.1054/bjoc.2001.1838 Text en Copyright © 2001 Cancer Research Campaign https://creativecommons.org/licenses/by/4.0/This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made.The images or other third party material in this article are included in the article’s Creative Commons license, unless indicated otherwise in a credit line to the material.If material is not included in the article’s Creative Commons license and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this license, visit https://creativecommons.org/licenses/by/4.0/. |
spellingShingle | Regular Article Soliman, A S Bondy, M L El-Badawy, S A Mokhtar, N Eissa, S Bayoumy, S Seifeldin, I A Houlihan, P S Lukish, J R Watanabe, T Chan, A On On Zhu, D Amos, C I Levin, B Hamilton, S R Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients |
title | Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients |
title_full | Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients |
title_fullStr | Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients |
title_full_unstemmed | Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients |
title_short | Contrasting molecular pathology of colorectal carcinoma in Egyptian and Western patients |
title_sort | contrasting molecular pathology of colorectal carcinoma in egyptian and western patients |
topic | Regular Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2375101/ https://www.ncbi.nlm.nih.gov/pubmed/11592777 http://dx.doi.org/10.1054/bjoc.2001.1838 |
work_keys_str_mv | AT solimanas contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT bondyml contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT elbadawysa contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT mokhtarn contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT eissas contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT bayoumys contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT seifeldinia contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT houlihanps contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT lukishjr contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT watanabet contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT chanaonon contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT zhud contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT amosci contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT levinb contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients AT hamiltonsr contrastingmolecularpathologyofcolorectalcarcinomainegyptianandwesternpatients |